
Arlen Soderquist
Examiner (ID: 17159, Phone: (571)272-1265 , Office: P/1797 )
| Most Active Art Unit | 1797 |
| Art Unit(s) | 1797, 1777, 1743, 1313, 1801, 1809 |
| Total Applications | 2208 |
| Issued Applications | 1375 |
| Pending Applications | 212 |
| Abandoned Applications | 644 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4720120
[patent_doc_number] => 20080242643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Nitric Oxide Releasing Prodrugs of Diaryl-2-(5H)-Furanones as Cyclooxygenase-2 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/586381
[patent_app_country] => US
[patent_app_date] => 2005-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9785
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242643.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586381
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586381 | Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors | Jan 24, 2005 | Issued |
Array
(
[id] => 4823180
[patent_doc_number] => 20080227758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Nitric Oxide Releasing Prodrugs of Diaryl-2-(5h)-Furanones as Cyclooxygenase-2 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/586573
[patent_app_country] => US
[patent_app_date] => 2005-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10841
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227758.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586573
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586573 | Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors | Jan 24, 2005 | Issued |
Array
(
[id] => 4705350
[patent_doc_number] => 20080064874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => '2-Halofuryl/Thienyl-3-Carboxamides'
[patent_app_type] => utility
[patent_app_number] => 10/588293
[patent_app_country] => US
[patent_app_date] => 2005-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27109
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064874.pdf
[firstpage_image] =>[orig_patent_app_number] => 10588293
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/588293 | 2-Halofuryl-thienyl-3-carboxamides | Jan 21, 2005 | Issued |
Array
(
[id] => 7250666
[patent_doc_number] => 20050272741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Novel methods of treatment for Fontan patients with protein losing enteropathy'
[patent_app_type] => utility
[patent_app_number] => 11/037966
[patent_app_country] => US
[patent_app_date] => 2005-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2432
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272741.pdf
[firstpage_image] =>[orig_patent_app_number] => 11037966
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/037966 | Novel methods of treatment for Fontan patients with protein losing enteropathy | Jan 17, 2005 | Abandoned |
Array
(
[id] => 4922612
[patent_doc_number] => 20080070928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Novel 2-Heteroaryl-Substituted Benzimidazole Derivative'
[patent_app_type] => utility
[patent_app_number] => 10/582564
[patent_app_country] => US
[patent_app_date] => 2004-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 148628
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070928.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582564
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582564 | 2-heteroaryl-substituted benzimidazole derivative | Dec 27, 2004 | Issued |
Array
(
[id] => 4682928
[patent_doc_number] => 20080249154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates'
[patent_app_type] => utility
[patent_app_number] => 10/584280
[patent_app_country] => US
[patent_app_date] => 2004-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24945
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249154.pdf
[firstpage_image] =>[orig_patent_app_number] => 10584280
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/584280 | Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates | Dec 23, 2004 | Abandoned |
Array
(
[id] => 5063527
[patent_doc_number] => 20070225167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => '2-Ethyl-4,6-Dimethyl-Phenyl-Substituted Tetramic Acid Derivatives as Pest Control Agents and/or Herbicides'
[patent_app_type] => utility
[patent_app_number] => 10/579099
[patent_app_country] => US
[patent_app_date] => 2004-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27344
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20070225167.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579099
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579099 | 2-Ethyl-4,6-Dimethyl-Phenyl-Substituted Tetramic Acid Derivatives as Pest Control Agents and/or Herbicides | Nov 8, 2004 | Abandoned |
Array
(
[id] => 5199651
[patent_doc_number] => 20070298969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => '2-Ethyl-4,6-Dimethyl-Phenyl-Substituted Spirocyclic Tetramic Acid Derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/578900
[patent_app_country] => US
[patent_app_date] => 2004-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23251
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20070298969.pdf
[firstpage_image] =>[orig_patent_app_number] => 10578900
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/578900 | 2-ethyl-4,6-dimethyl-phenyl-substituted spirocyclic tetramic acid derivatives | Nov 8, 2004 | Issued |
Array
(
[id] => 4652379
[patent_doc_number] => 20080039635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Method for the Production of a Compound, Comprising a Free Hydroxyl Group and a Hydroxyl Group Which is Protected by an Ester Function by Enzymatic Reaction'
[patent_app_type] => utility
[patent_app_number] => 10/576773
[patent_app_country] => US
[patent_app_date] => 2004-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4517
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039635.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576773
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576773 | Method for the Production of a Compound, Comprising a Free Hydroxyl Group and a Hydroxyl Group Which is Protected by an Ester Function by Enzymatic Reaction | Oct 18, 2004 | Abandoned |
Array
(
[id] => 4887913
[patent_doc_number] => 20080262245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Process for the Preparation of Amorphous Fluvastatin Sodium'
[patent_app_type] => utility
[patent_app_number] => 11/576714
[patent_app_country] => US
[patent_app_date] => 2004-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 824
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262245.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576714
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576714 | Process for the preparation of amorphous fluvastatin sodium | Oct 4, 2004 | Issued |
Array
(
[id] => 5068917
[patent_doc_number] => 20070190018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Dual phase drug release system'
[patent_app_type] => utility
[patent_app_number] => 10/570466
[patent_app_country] => US
[patent_app_date] => 2004-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 29024
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20070190018.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570466
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570466 | Dual phase drug release system | Sep 3, 2004 | Issued |
Array
(
[id] => 185181
[patent_doc_number] => 07648997
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-19
[patent_title] => 'Hydroxylamine substituted imidazoquinolines'
[patent_app_type] => utility
[patent_app_number] => 10/595058
[patent_app_country] => US
[patent_app_date] => 2004-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39378
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/648/07648997.pdf
[firstpage_image] =>[orig_patent_app_number] => 10595058
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/595058 | Hydroxylamine substituted imidazoquinolines | Aug 11, 2004 | Issued |
Array
(
[id] => 4705167
[patent_doc_number] => 20080064691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Heterocyclic Amide Derivatives Which Possess Glycogen Phosphorylase Inhibitory Activity'
[patent_app_type] => utility
[patent_app_number] => 10/566063
[patent_app_country] => US
[patent_app_date] => 2004-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39219
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064691.pdf
[firstpage_image] =>[orig_patent_app_number] => 10566063
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/566063 | Heterocyclic Amide Derivatives Which Possess Glycogen Phosphorylase Inhibitory Activity | Aug 3, 2004 | Abandoned |
Array
(
[id] => 131919
[patent_doc_number] => 07700619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-20
[patent_title] => '2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts'
[patent_app_type] => utility
[patent_app_number] => 10/566384
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4798
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/700/07700619.pdf
[firstpage_image] =>[orig_patent_app_number] => 10566384
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/566384 | 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts | Jul 28, 2004 | Issued |
Array
(
[id] => 7075253
[patent_doc_number] => 20050148521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Anti-cancer combination and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/898721
[patent_app_country] => US
[patent_app_date] => 2004-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8375
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 38
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148521.pdf
[firstpage_image] =>[orig_patent_app_number] => 10898721
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/898721 | Anti-cancer combination and use thereof | Jul 22, 2004 | Abandoned |
Array
(
[id] => 5000386
[patent_doc_number] => 20070043020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds'
[patent_app_type] => utility
[patent_app_number] => 10/563708
[patent_app_country] => US
[patent_app_date] => 2004-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11999
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20070043020.pdf
[firstpage_image] =>[orig_patent_app_number] => 10563708
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/563708 | Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds | Jul 6, 2004 | Issued |
Array
(
[id] => 5101870
[patent_doc_number] => 20070185132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereo'
[patent_app_type] => utility
[patent_app_number] => 10/559869
[patent_app_country] => US
[patent_app_date] => 2004-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19630
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185132.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559869
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559869 | Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereo | Jun 28, 2004 | Abandoned |
Array
(
[id] => 7060535
[patent_doc_number] => 20050002895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Methods and compositions for controlled release of drugs'
[patent_app_type] => utility
[patent_app_number] => 10/859472
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21813
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002895.pdf
[firstpage_image] =>[orig_patent_app_number] => 10859472
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/859472 | Methods and compositions for controlled release of drugs | May 31, 2004 | Issued |
Array
(
[id] => 5786868
[patent_doc_number] => 20060205804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Process for preparing 5-(4-fluorophenyl)-1-[2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl) ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide'
[patent_app_type] => utility
[patent_app_number] => 10/552747
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6269
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205804.pdf
[firstpage_image] =>[orig_patent_app_number] => 10552747
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/552747 | Process for preparing 5-(4-fluorophenyl)-1-[2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl) ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide | Mar 30, 2004 | Abandoned |
Array
(
[id] => 4978144
[patent_doc_number] => 20070219378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Method for Producing Sodium Fosphenytoin'
[patent_app_type] => utility
[patent_app_number] => 10/587189
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2421
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219378.pdf
[firstpage_image] =>[orig_patent_app_number] => 10587189
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587189 | Method for Producing Sodium Fosphenytoin | Feb 4, 2004 | Abandoned |